Beleben Pharma Private Limited - Company Profile

It is a business services private limited company based in Pune, Maharashtra, India, established in 2018.
2018 Pune, Maharashtra, India Active
Last Updated:
About Beleben Pharma Private Limited

Beleben Pharma Private Limited, a active private limited company, was established on 05 June 2018 in Pune, Maharashtra, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999PN2018PTC177003. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹50.00 K and a paid-up capital of ₹50.00 K .

Its leadership includes Abhijit Balkrishna Bauskar (Director), Vishal Balkrishna Bauskar (Director). Past directors included Nilima Prakash Mahajan, Vishal Balkrishna Bauskar. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Wing No A Fl.No 8 S .No 20/2,20/3 Ganesh Garden Dapodi, Pune, Maharashtra, 411012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999PN2018PTC177003

  • Registration Number

    177003

  • Incorporation Date

    05 June 2018

  • Authorized Capital

    ₹50.00 K

  • Paid-Up Capital

    ₹50.00 K

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 K
  • Paid Up Capital ₹ 50.00 K
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** %
  • Net Worth 40.60%
  • Total Assets **** 1278.24%
Company report

Beleben Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Beleben Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Beleben Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Abhijit Balkrishna Bauskar Director 05 Jun 2018 Current
Vishal Balkrishna Bauskar Director 22 Feb 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Feb 2019 Past
Pramod Abcsdd Additional Director 30 Dec 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Beleben Pharma.

Beleben Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 40.6%.

Beleben Pharma revenue growth over time
Beleben Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
1278.24%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
40.60%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Beleben Pharma?

Unlock access to Beleben Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Beleben Pharma?

Unlock and access historical data on people associated with Beleben Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Beleben Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beleben Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Beleben Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Beleben Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.

  • Balance Sheet

    Beleben Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Pune. was recorded as a recent event.

  • Director Appointment

    Vishal Balkrishna Bauskar was appointed as a Director was appointed as a Director on 22 Feb 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.

  • Director Appointment

    Abhijit Balkrishna Bauskar was appointed as a Director was appointed as a Director on 05 Jun 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.

  • Company Incorporation

    Beleben Pharma Private Limited was registered on 05 Jun 2018 with Roc Pune & aged 7 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Beleben Pharma Private Limited?

The CIN of Beleben Pharma Private Limited is U74999PN2018PTC177003.

Where is Beleben Pharma Private Limited headquartered?

Beleben Pharma Private Limited is headquartered at Wing No A Fl.No 8 S .No 20/2,20/3 Ganesh Garden Dapodi, Pune, Maharashtra, 411012.

When was Beleben Pharma Private Limited incorporated?

Beleben Pharma Private Limited was incorporated on 05 June 2018.

Who are the current directors of Beleben Pharma Private Limited?

The current directors of Beleben Pharma Private Limited are

What is the primary industry of Beleben Pharma Private Limited?

The primary industry of Beleben Pharma Private Limited is Business Services.

Is Beleben Pharma Private Limited a listed company?

Beleben Pharma Private Limited is unlisted.

What is the capital structure of Beleben Pharma Private Limited?

The authorized capital of Beleben Pharma Private Limited is ₹50.00 K , and the paid-up capital is ₹50.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available